NewAmsterdam Pharma (NAMS) Stock
NewAmsterdam Pharma (NAMS) closed at $19.88 on Nov 16, 2026; its Tenet Score is 58 of 100 against 297 Healthcare peers.
23 figures withheld by our checks. Each blank figure names its reason.
Key stats
- Previous close
- $19.88
- Nov 16, 2026
- Market cap
- $2.4B
- share price × the latest quarter's diluted weighted-average share count (vendor)
- 52-week range
- 17.90 – 42.20
- low → high · as of close, Nov 13, 2026
- Tenet Score
- 58/100
- Mixed · 297 Healthcare peers
Industry: Drugs
NewAmsterdam Pharma Company NV scores 58/100. Mixed. Strongest on financial health, quality is the soft spot versus 297 Healthcare peers. Insufficient inputs: Tenet 58 is built from 3 of 4 pillars, from 50% of its inputs. Growth is left out because no growth rate could be measured.
Tenet Score · vs sector
n=297Factor grades
Growth omitted — no data yet.
Price
The whole report, at a glance · every card is a live peek, click any to open the section
- ✕ Buffett Quality
- ✕ Piotroski F-Score
- ✕ Graham Defensive
- ✕ Quality Compounder
- ✕ Drawdown Context
- ✕ Reversal Evidence
Similar-sized companies in Drugs
The 10 companies in this industry closest in market cap, as of Nov 13, 2026.
| Company | Tenet Score | Market cap |
|---|---|---|
| HUTCHMED (China) LimitedHCM | 61 | $2.6B |
| Arcus Biosciences IncRCUS | 31 | $2.5B |
| Neogen Corp.NEOG | 45 | $2.5B |
| Regencell Bioscience Holdings LtdRGC | 30 | $2.4B |
| Beam Therapeutics IncBEAM | 60 | $2.4B |
| Celldex Therapeutics Inc.CLDX | 45 | $2.3B |
| Perrigo Company plcPRGO | 40 | $2.3B |
| Lakefront Biotherapeutics NVLKFT | 82 | $2.2B |
| Schrodinger IncSDGR | 40 | $2.2B |
| Immunome IncIMNM | 49 | $2.2B |
Common questions
What sector and industry is NewAmsterdam Pharma in?
NewAmsterdam Pharma is in the Healthcare sector and the Drugs industry.
What is NewAmsterdam Pharma's Tenet Score?
NewAmsterdam Pharma's Tenet Score is 58 out of 100, ranked against 297 Healthcare peers as of Nov 13, 2026.




